Clearance Summary
Callaly Tampliner received FDA 510(k) clearance under submission number K211469, sponsored by Calla Lily Personal Care, Ltd.. The device was reviewed via the Special premarket notification pathway and assigned to the Obstetrics/Gynecology review panel. The statutory decision date of record is 2021-06-10.
- Submission: K211469
- Applicant / Sponsor: Calla Lily Personal Care, Ltd.
- Clearance pathway: Special
- Review panel: Obstetrics/Gynecology
- Device class: Class II
- Regulation citation: 21 CFR 884.5470
- Decision date: 2021-06-10
Classification & Regulation
This clearance is catalogued under FDA product code HEB and 21 CFR 884.5470, within the Obstetrics/Gynecology review panel as a Class II device.